核磁共振波谱法测定依非韦伦含量

分别采用氢核磁共振定量法和氟核磁共振定量法测定依非韦伦含量。氢核磁共振定量法以依非韦伦δ1.58～1.65处质子峰为定量峰,马来酸δ6.22处为内标峰。氟核磁共振定量法以δ-80.58处作为定量峰,4-溴-2-氟-乙酰苯胺δ-121.70作为内标峰。通过比较依非韦伦的定量峰与内标物质内标峰峰面积,计算依非韦伦的含量。测试结果显示,氢核磁共振定量法和氟核磁共振定量法的含量测定结果基本一致。因此,核磁共振法可用于依非韦伦绝对含量的测定,具有快速、准确的优势。     

核磁共振定量法测定利培酮含量

采用氢核磁共振定量法和氟核磁共振定量法测定利培酮含量。氢核磁共振定量法以利培酮δ7.29~7.35处质子峰为定量峰,马来酸δ6.02处为内标峰,在恒温300 K,采样时间4.0 s,弛豫延迟时间15 s,扫描次数为32次条件下采集氢谱。氟核磁共振定量法以4-溴-2-氟-乙酰苯胺为内标,在恒温300 K,谱宽12 500.0 Hz,中心频率-43 662.7 Hz下采集氟谱。测试结果显示,利培酮氢核磁共振定量法和氟核磁共振定量法的含量测定结果基本与质量平衡法的结果一致。因此,核磁共振法可用于利培酮绝对含量的测定,具有快速、简单、准确的优势。     

新型N,N′-二(邻氧乙酸)苄叉丙二胺合铜(II)和镍(Ⅱ)及N-(邻氧乙酸)苄叉丙二胺合铜(Ⅱ)的合成、晶体结构及抑菌活性

在乙醇和水的混合溶液中,将N,N′-二(邻氧乙酸)苄叉丙二胺(1)与氯化铜反应,获得配合物Cu(Ⅱ)L1.H2O.0.25CH3CH2OH(2)[L1=N,N′-二(邻氧乙酸)苄叉丙二胺];当将反应混合溶液的pH值调至8~9,获得Cu(Ⅱ)ClL2.3H2O(3)[L2=N-(邻氧乙酸)苄叉丙二胺];将N,N′-二(邻氧乙酸)苄叉丙二胺(1)与氯化镍反应,获得配合物Ni(Ⅱ)L1.2.75H2O(4).用元素分析、1H NMR和IR谱等方法对所合成的化合物1和配合物2~4进行了表征,并测定了配合物2~4的晶体结构.在配合物2中,铜原子为六配位[CuN2O4],在配合物3中,铜原子为六配位[CuN2O3Cl],在配合物4中,镍原子为六配位[NiN2O4],三个配合物均为畸变八面体结构.抑菌活性大小的顺序:配合物3>配合物2>化合物1.     

N催化剂中活性组分的核磁共振氢谱定量研究

建立了测定无对照品的N催化剂中活性组分含量的核磁共振氢谱内标测定法。以氘代甲醇为溶剂,对苯二酚为内标物,设定合适的采样时间和延迟时间,选取适合的内标峰和样品定量峰。采用优化后的实验参数进行定量分析,经计算得其中的活性组分磷酸三丁酯(TBP)、邻苯二甲酸酐开环产物(PA-DCPTi Cl3)、环氧氯丙烷开环产物(DCP-Ti Cl3)和邻苯二甲酸正丁酯(DNBP)的质量分数分别为0.21%、0.58%、1.21%和5.82%,相对标准偏差(RSD)分别为0.75%、0.89%、0.41%和0.35%,其结果的重复性和可靠性良好,与高效液相色谱法测定结果一致。该方法具有无需标准对照品、快速、高效等特点,在利用核磁共振技术研究N催化剂中活性组分的化学结构时可同时测定其含量,为催化剂中给电子体含量的表征建立了新途径。     

^(1)H和^(19)F核磁共振定量法测定诺氟沙星标准品的绝对含量EI北大核心CSCD

采用^(1)H和^(19)F核磁共振定量法测定诺氟沙星标准品的绝对含量。^(1)H核磁共振定量法以DMSO-d6为溶剂,诺氟沙星峰(δ7.9)为定量峰,马来酸峰(δ6.3)为内标峰。在脉冲程序zg30,采样时间4.09 s,延迟时间20 s,扫描次数为16的条件下采集氢谱。^(19)F核磁共振定量法以利培酮为内标物,诺氟沙星峰(δ-121.3)为定量峰,利培酮峰(δ-109.9)为内标峰。在脉冲程序zgfhigqn.2,延迟时间7 s,扫描次数为16的条件下采集氟谱。^(1)H和^(19)F核磁共振定量法测定结果接近,且与质量平衡法测定结果一致。核磁共振定量法可用来测定诺氟沙星绝对含量,快速、简单高效、且不需要对照品。     

Zn取代类水滑石衍生复合氧化物上N2O的催化分解

恒定二价与三价阳离子比为3((nZn+nMg)/nAl=3), 采用共沉淀法制备不同Zn含量的系列类水滑石前驱物ZnxMg3-xAl-HT (x=0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0), 经焙烧得到其衍生复合氧化物催化剂ZnxMg3-xAlO, 用于N2O的直接催化分解. 采用X射线衍射(XRD)、比表面积分析(Brunauer-Emmett-Teller)、热分析(TG-DSC)和傅里叶变换红外(FT-IR)光谱等表征手段考察了Zn含量对材料前驱物及其衍生复合氧化物组成和结构的影响, 研究了系列ZnxMg3-xAlO催化剂的N2O催化分解性能, 同时探讨了反应条件, 如N2O浓度、空速、O2和H2O等因素对催化剂活性的影响. 结果表明, 所有前驱物材料均能形成完整的层状水滑石结构; 经高温焙烧后形成了以Zn-Al尖晶石为主相的复合氧化物, 且Zn掺杂有助于促进尖晶石相的生成; Zn含量对材料的热稳定性、比表面积和N2O催化分解活性有显著的影响; 随着Zn含量增加, 催化剂比表面积下降, 但其不是影响催化剂活性的主要因素; 650 ℃焙烧后的Zn2.0Mg1.0AlO催化剂具有较好的N2O催化分解活性; N2O浓度、空速及O2对催化剂活性的影响较小, 而H2O则对活性有较大的影响.     

Zn取代类水滑石衍生复合氧化物上N2O的催化分解

恒定二价与三价阳离子比为3((nZn+nMg)/nAl=3),采用共沉淀法制备不同Zn含量的系列类水滑石前驱物ZnxMg3-xAl-HT (x=0,0.5,1.0,1.5,2.0,2.5,3.0),经焙烧得到其衍生复合氧化物催化剂ZnxMg3-xAlO,用于N2O的直接催化分解.采用X射线衍射(XRD)、比表面积分析(Brunauer-Emmett-Teller)、热分析(TG-DSC)和傅里叶变换红外(FT-IR)光谱等表征手段考察了Zn含量对材料前驱物及其衍生复合氧化物组成和结构的影响,研究了系列ZnxMg3-xAlO催化剂的N2O催化分解性能,同时探讨了反应条件,如N2O浓度、空速、O2和H2O等因素对催化剂活性的影响.结果表明,所有前驱物材料均能形成完整的层状水滑石结构;经高温焙烧后形成了以Zn-Al尖晶石为主相的复合氧化物,且Zn掺杂有助于促进尖晶石相的生成;Zn含量对材料的热稳定性、比表面积和N2O催化分解活性有显著的影响;随着Zn含量增加,催化剂比表面积下降,但其不是影响催化剂活性的主要因素;650℃焙烧后的Zn2.0Mg1.0AlO催化剂具有较好的N2O催化分解活性;N2O浓度、空速及O2对催化剂活性的影响较小,而H2O则对活性有较大的影响.     

N,N′,N″-三(2-羟基-1-萘酚醛)胺稀土配合物的合成及其荧光性能的初探

预先制备了N,N′,N″-三(2-羟基-1-萘酚醛)胺作为配体(L),然后向含配体L的乙醇-二氯甲烷溶液中加入含稀土硝酸盐晶体RE(NO3)3.6 H2O(RE=La3+,Sm3+,Y3+,Tb3+,Ce3+,Eu3+)的乙醇溶液,合成稀土配合物。利用核磁共振法、元素分析法、摩尔电导法、红外光谱法及差热-热重法对稀土配合物的结构进行表征。结果表明:稀土配合物的结构为RE(NO3)3.L.4 H2O。采用荧光技术对稀土配合物的性能进行了研究,结果表明:在pH值约为7的介质中,以二甲亚砜(DMSO)为溶剂,稀土配合物浓度为1.0×10-4mol.L-1时,铽(Ⅲ)配合物有较强的特征荧光发射,铕(Ⅲ)配合物只表现了微弱的特征荧光发射,其他稀土配合物没有特征荧光发射。     

两个2,6-二氨基-3,5-二硝基吡嗪-1-氧化物含能配合物的合成、晶体结构及催化性能(英文)

合成了2,6-二氨基-3,5-二硝基吡嗪-1-氧化物(LLM-105)2种含能配合物[Cu4O2(C4N6O5H2)2(CH3COO)2(DMF)2]·DMF(1)((C4N6O5H2)2-为配体LLM-105失去2个H+)和[Co(C4N6O5H3)3]·7H2O(2)((C4N6O5H3)-为LLM-105失去1个H+),用X射线单晶衍射法测定了其分子结构。配合物1属正交晶系,空间群为Pbca,配合物2属三斜晶系,空间群为R3。用DSC,TG-DTG技术对配体和2个配合物的热分解进行了研究。用Kissinger法和Ozawa-Doyle法对配合物热分解过程中放热峰的表观活化能进行了计算。同时研究了2种配合物对AP热分解催化效果的影响,结果表明,2种配合物使AP的高温分解峰温分别提前117.42和71.85℃,分解放热量增加1 916.97和1 433.76 J·g-1,对AP热分解具有非常显著的催化效果。     

气相色谱法测定新型卷烟气溶胶中水、烟碱、1,2-丙二醇和丙三醇的含量北大核心CSCD

提出了同时测定新型卷烟气溶胶中水、烟碱、1,2-丙二醇和丙三醇的气相色谱双柱双检测器法。采用Φ44mm剑桥滤片捕集5支新型卷烟中气溶胶总粒相物,剑桥滤片用20mL含3种内标的异丙醇溶液(乙醇为水的内标,2-甲基喹啉为烟碱的内标,1,4-丁二醇为1,2-丙二醇和丙三醇的内标)振荡萃取10min,萃取液过0.22μm滤膜后进行气相色谱分析。采用Porapak Q2填充柱和热导检测器检测水,采用DB-ALC色谱柱和氢火焰离子化检测器检测烟碱、1,2-丙二醇和丙三醇,内标法定量。结果表明:水、烟碱、1,2-丙二醇和丙三醇的质量浓度在一定范围内与其峰面积和内标峰面积的比值呈线性关系,检出限(3S/N)分别为0.08,0.01,0.02,0.05mg·支-1。按标准加入法进行回收试验,回收率为92.3%～103%,测定值的相对标准偏差(n=6)为2.4%～9.8%。     

多种方法分析与评价乙酸乙酯合成实验中产物之纯度

采用气相色谱内标法、面积归一化法及NMR内标法3种方法对乙酸乙酯合成反应中的产物进行纯度分析.GC内标法可抵消由于操作条件的波动而带来的误差,只需内标物与待测组分在同样条件下出峰且分离度较好,定量精度高,测出的乙酸乙酯纯度最低;应用NMR内标法可同步完成纯度分析和结构鉴定,且无需引入校正因子,操作简便.     

核磁共振法测定西洛他唑含量

建立核磁共振（1H NMR）法测定西洛他唑含量的方法。采用BrukerAvanceⅢ400MHz核磁共振波谱仪,以1,2,4,5-四氯-3-硝基苯为内标,氘代氯仿为溶剂,zg30脉冲序列。对实验参数如扫描次数、延迟时间等进行优化。西洛他唑质量在5-30mg范围内,样品和内标物的积分面积比值与样品和内标物的质量比值呈现良好的线性关系,线性相关系数r=0．9953,测定结果的相对标准偏差小于0．4％（n=5）。该方法可用于药品的质量控制和监管。     

核磁共振波谱法测定药物基准物质的绝对含量

探讨在新药基准物质的确定过程中,利用核磁共振法测定药物绝对含量的可行性。以环丙沙星、安妥沙星、卡德沙星、加替沙星、左氧氟沙星、氧氟沙星、诺氟沙星、依诺沙星和洛美沙星9种喹诺酮类抗生素化学对照品为例,其中安妥沙星和卡德沙星为国家一类新药。采用重水、氘代二甲基亚砜或氢氧化钠的重水溶液为溶剂,对苯二酚或顺丁烯二酸为内标,用喹诺酮母核上的质子峰进行定量,以内标法和外标法计算含量。核磁共振法测定结果与各对照品标签示值的误差约为1％,内标法和外标法的计算结果一致。该方法专属、准确、简便、快速,适用于对药物基准物质绝对含量的测定。     

定量核磁法测定CL-20标准物质中有机杂质的含量

采用定量核磁共振波谱法(qNMR)测定六硝基六氮杂异伍兹烷(CL-20)标准物质中有机杂质的含量。核磁谱图解析证明,主要有机杂质成分为残余溶剂乙酸乙酯和中间体五硝基-乙酰基六氮杂异伍兹烷(MPIW),以不含四甲基硅烷(TMS)的氘代丙酮为溶剂,将六甲基二硅醚的四氯化碳标准溶液加入待测液中作为内标,以其谱峰(δ=0.06)作为内标峰对两种有机杂质进行定量分析。考察了延迟时间和采样次数对准确定量的影响,结果显示为确保定量结果的准确性,延迟时间D_1应不小于20 s,采样次数为32次。采用优化后的实验参数进行纯度分析,测得CL-20标准物质中有机杂质乙酸乙酯和MPIW的质量分数分别为0.03516%和0.156 2%,相对标准偏差(RSD)分别为0.91%和0.86%。     

Phosphate additives determination in meat products by 31-phosphorus nuclear magnetic resonance using new internal reference standard: hexamethylphosphoroamide

New ³¹P NMR internal reference standard - hexamethylphosphoroamide (HMPA) was applied for determination of added polyphosphates and their ionic forms in raw pork meat and meat products. Phosphate species were determined after extraction with a boric acid buffer (pH = 9) and EDTA solution, using internal standard (HMPA) procedure. Hexamethylphosophoroamide was also used as the NMR reference standard. Linear correlations between phosphates and polyphosphate concentrations and ³¹P NMR signal areas were found in the range 81-5236 mg P/dm³, presenting 95-99% recovery and variation coefficient (CV) ≤ 5%. Studied HMPA procedure revealed shorter analysis time and the same recovery (>95%) and precision (CV = 1.3-2.7%) in comparison to MDPA method. Results of phosphate determination by both ³¹P NMR methods were tested against the molybdenumvanadate yellow spectrophotometric method (standard PN-ISO 13730, 1999) using standard reference material (certified phosphate solution).     

Novel sensitive determination of steryl glycosides in biodiesel by gas chromatography–mass spectroscopy

A new method was developed for the quantitative analysis of steryl glycosides in biodiesel (fatty acid methyl esters). This method is much more sensitive than existing methods and has minimum limits of quantification of 50 μg/kg, compared to previously published minimum limits of quantification of about 15 mg/kg. The analysis is based on gas chromatography–mass spectroscopy determination of simple pre-treated and silylated samples via single ion monitoring at 147, 204, 217 m/z, which are specific ions for the silylated sugar moiety. Quantification was carried out using cholesteryl β-d-glucopyranoside as internal standard. The modified synthesis and purification of the internal standard is also presented as well as the characterization by NMR and mass spectroscopy. The advantage of the method compared with other approaches is the simplified sample preparation avoiding extra pre-treatment steps coupled with complete derivatization of the sugar hydroxyl groups by using N,O-bis(trimethylsilyl)acetamide with 5% trimethylchlorosilane as derivatization reagent. On the given conditions high recovery rates ≥89% can be obtained. Evaluation of lab specific variance and intermediate precision underline the robustness of the method which will be further assessed by Round robin tests.     

Quantitation of memantine hydrochloride bulk drug and its tablet formulation using proton nuclear magnetic resonance spectrometry

The use of quantitative nuclear magnetic resonance spectrometry for the determination of non‐UV active memantine hydrochloride with relative simplicity and precision has been demonstrated in this study. The method was developed on a 500 MHz NMR instrument and was applied to determination of the drug in a tablet formulation. The analysis was performed by taking caffeine as an internal standard and D₂O as the NMR solvent. The signal of methyl protons of memantine hydrochloride appeared at 0.75 ppm (singlet) relative to the signal of caffeine (internal standard) at 3.13 ppm (singlet). The method was found to be linear (r² = 0.9989) in the drug concentration range of 0.025 to 0.80 mg/ml. The maximum relative standard deviation for accuracy and precision was <2. The limits of detection and quantification were 0.04 and 0.11 mg/ml, respectively. The robustness of the method was revealed by changing nine different parameters. The deviation for each parameter was also within the acceptable limits. The study highlighted possibility of direct determination of memantine hydrochloride in pure form and in its marketed tablet formulation by the use of quantitative NMR, without the need of derivatization, as is the requirement in HPLC studies. Copyright © 2016 John Wiley & Sons, Ltd.     

一种蛋白同化激素新药的成分分析及其尿样监控

利用红外光谱、核磁共振氢谱、紫外光谱以及质谱等表征手段对一种新型蛋白同化激素(AAS)口服药物的主成分进行了研究和鉴定,推定主成分为甲基-1-睾酮(methyl-1-testosterone, M1T, 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one)。在此基础上,建立了M1T的气相色谱-质谱联用检测方法。方法的检出限（信噪比（S/N)为3)为2 ng/mL,定量限（S/N=10）为10 ng/mL;7次平行测定前处理后的加内标尿样的相对标准偏差为9.8%。用该方法测定了该药物在尿样中的排泄曲线。该方法的建立为AAS新药的发现、检测和监控做了很有意义的基础研究工作。     

核磁共振法测定片剂中西咪替丁

建立以核磁共振技术测定片剂中西咪替丁含量的方法。采用Agilent DD2-500型核磁共振波谱仪,以氘代甲醇为溶剂、对苯二甲酸二甲酯为内标,测试温度25℃,弛豫时间为20 s,脉冲角为45°,采集时间为2 s,扫描次数为16次,采集核磁共振氢谱。该方法线性范围为0.1~5.0 mg/mL,相关系数r=0.999 8,测定结果的相对标准偏差为0.11%(n=6),平均加标回收率在100.03%~100.58%之间。用该方法测定不同厂家片剂中西咪替丁的含量,测定结果与药典方法相吻合。该方法简单快速、样品用量少,适用于西咪替丁的质量控制。     

H nuclear magnetic resonance spectroscopy analysis for simultaneous determination of levodopa, carbidopa and methyldopa in human serum and pharmaceutical formulations

A method utilizing NMR spectroscopy has been developed to confirm the identity and quantity of levodopa, carbidopa and methyldopa in human serum and pharmaceutical preparations. The method is based on 500 MHz proton NMR spectra of individual catecholamine molecules. Qualitative and quantitative analyses are based on resonance characteristics of the functional groups present in their structures and the integral ratio of selected signals belonging to different compounds with respect to those of an internal standard, respectively. Experiments are performed to validate the quantitative NMR method, and the linearity and reproducibility of the proposed method are verified. The detection limit of the proposed method was estimated as 4.2, 1.7 and 1.6  μg ml⁻¹ for levodopa, carbidopa and methyldopa, respectively. The recovery studies performed on human serum samples ranged from about 82-96% with relative standard deviations of <4%. The method was also applied successfully to the determination of each active compound in real pharmaceutical samples, and compared with the results obtained by the reference methods. The method is rapid, precise, accurate, and suitable for routine analyses.